×
Don't Miss Out!
Get your weekly Breakfast Briefing eNewsletter, filled with news, trends, and vital information from DIA!
Back to Agenda
Session 20: Spontaneous Case Report
Session Chair(s)
Mark Vieder, MBA, RPh
Vice President, Drug Safety and Pharmacovigilance
Biorasi, LLC, United States
Attendees will review a spontaneous case report for a fictitious marketed product to determine seriousness, expectedness and regulatory reporting requirements.
Have an account?